Key Points An analyst initiated coverage of the healthcare stock. He's flagged it as a buy at the current price. 10 stocks we like better than Scholar Rock › Monday was a good day to be invested in Scholar Rock (NASDAQ: SRRK) stock. The clinical-stage biotech received a nod from an analyst initiating coverage on its shares, a move that sent its price more than 6% higher across the day. That rate was well higher than the 0.5% increase of the S&P 500 index. A bullish start Well before market open, ...